Pathway Genomics – BreastTrue® High Risk Panel

Check with vendor TAKE THE TEST

BreastTrue® High Risk Panel is a next-generation sequencing test with deletion/duplication analysis to detect mutations in seven high-risk breast cancer susceptibility genes, including BRCA1, BRCA2 and PALB2.Recent studies of breast cancer survivors have shown that approximately 70 percent of the mutations identified were BRCA1/2 mutations. Approximately 4 percent had germline mutations in other cancer-susceptibility genes, including high-risk genes. These additional high-risk genes include CDH1, PALB2, PTEN, STK11, and TP53. Pathway Genomics® BreastTrue® High Risk Panel analyzes all of these genes.

We have not reviewed this DNA test yet. If you have taken this test, please scroll down and click “Add your review.” All DNA tests that have not been reviewed receive a default score of 6/10 until reader reviews change the score.

BreastTrue® High Risk Panel is a next-generation sequencing test with deletion/duplication analysis to detect mutations in seven high-risk breast cancer susceptibility genes, including BRCA1, BRCA2 and PALB2.Recent studies of breast cancer survivors have shown that approximately 70 percent of the mutations identified were BRCA1/2 mutations. Approximately 4 percent had germline mutations in other cancer-susceptibility genes, including high-risk genes. These additional high-risk genes include CDH1, PALB2, PTEN, STK11, and TP53. Pathway Genomics? BreastTrue? High Risk Panel analyzes all of these genes.
Check with vendor
PROS:

Coming soon Coming soon

CONS:
Coming soon Coming soon

6 Total Score
Pathway Genomics - BreastTrue® High Risk Panel

BreastTrue® High Risk Panel is a next-generation sequencing test with deletion/duplication analysis to detect mutations in seven high-risk breast cancer susceptibility genes, including BRCA1, BRCA2 and PALB2.Recent studies of breast cancer survivors have shown that approximately 70 percent of the mutations identified were BRCA1/2 mutations. Approximately 4 percent had germline mutations in other cancer-susceptibility genes, including high-risk genes. These additional high-risk genes include CDH1, PALB2, PTEN, STK11, and TP53. Pathway Genomics® BreastTrue® High Risk Panel analyzes all of these genes.

Turnaround time
6
Ease of test
6

DNA Test Review
Compare items
  • Total (0)
Compare
0